/ Company

STEFAN FESKE, M.D., Co-founder

Assistant Professor of Pathology, New York University (NYU) School of Medicine
Co-founder, CalciMedica

Dr. Feske’s research is focused on signaling pathways in T cells, particularly store-operated calcium entry, calcium channel function and NFAT activation. Dr. Feske joined Dr. Anjana Rao’s laboratory at Harvard Medical School (HMS) in 1998 as a postdoctoral fellow to work on the role of NFAT in inherited immune deficiency. He became an instructor in the Department of Pathology at HMS in 2001 and assistant professor in the Department of Pediatrics at HMS in 2004. Since 2007 he is an assistant professor in the Department of Pathology at New York University (NYU) Medical Center in New York City. In collaboration with Dr. Anjana Rao, he has investigated the role of several proteins in the Icrac signaling pathway, including STIM1 and NFAT, in human immune deficiency syndromes, and recently used this model to clone Orai1, a novel gene essential for CRAC channel function. In collaboration with Dr. Rao’s lab, Dr. Feske is currently developing several mouse models to study the role of STIM1, STIM2 and Orai1 in the Icrac pathway and in immune responses. Dr. Feske studied medicine at the Universities of Hamburg and Freiburg in Germany, where he graduated in 1996 summa cum laude. He completed his residency in the Department of Clinical Immunology and Rheumatology at the University Hospital in Freiburg.